proteindegradation.com
Open in
urlscan Pro
5.134.13.35
Public Scan
Submitted URL: https://info.hansonwade.com/e/448062/imary-unengaged-em-05-ev-33866/b36jqb/1424077473?h=82Sk9041nL770yAwnddqGWylZtUSmS_xqMB1...
Effective URL: https://proteindegradation.com/?utm_source=internal&utm_medium=email&utm_campaign=scheduled-call&utm_content=primary-unengaged%...
Submission: On June 23 via manual from IN — Scanned from DE
Effective URL: https://proteindegradation.com/?utm_source=internal&utm_medium=email&utm_campaign=scheduled-call&utm_content=primary-unengaged%...
Submission: On June 23 via manual from IN — Scanned from DE
Form analysis 1 forms found in the DOM
GET https://proteindegradation.com/
<form role="search" method="get" id="searchform" class="searchform" action="https://proteindegradation.com/">
<div>
<label class="screen-reader-text" for="s"> Search</label>
<input type="text" value="" name="s" id="s" placeholder="">
<input type="submit" id="searchsubmit" value="Search">
</div>
</form>Text Content
Skip to content
October 30 - November 2, 2023
Boston, MA
2023 Event Program
Menu
* Home
* About
* About TPD
* Agenda at a Glance
* Venue & Accommodation
* Who Attends?
* Poster Submission Abstract
* Attendee Insight
* Market Insights
* Gallery
* Program
* Full Event Guide
* Expert Speakers
* Agenda
* Pre-Conference Day
* Conference Day 1
* Conference Day 2
* Post-Conference Focus Day
* Partnership
* Partnership Opportunities
* 2023 Partners
* Take Part
* Register
* Contact Us
2023 EVENT GUIDE
REGISTER
PARTNER
6TH TARGETED PROTEIN DEGRADATION SUMMIT
Spearheading Degrader Therapeutics Towards the First Approval
This Fall, the world’s longest-standing and most comprehensive TPD meeting, the
6th Targeted Protein Degradation Summit, returns to Boston in 2023 as the
trusted, definitive, end-to-end forum for the global network of protein
degradation drug developers.
Ensure your whole team stays connected and miles ahead of the curve with
unmatched industry insights across early discovery, through the clinic and
towards approval.
Spanning the full breadth of PROTAC and molecular glue clinical development, to
unveiling next generation strategies including AbTACs, DUBTACs, bioPROTACs,
ATACs, AUTOTACs and more, this meeting is your definitive opportunity to
troubleshoot challenging problems and inspire new ideas with peers.
Relive the 2022 Event Highlights:
2023 FULL EVENT GUIDE
THE BIGGEST MEETING IN THE TARGETED PROTEIN DEGRADATION CALENDAR:
100+ Speakers
200+ Companies
700+ Attendees
4 Specialized Tracks
6 Deep Dive Workshops
4 Days of Content
View Full Event Schedule
UNITING THE WORLD’S LEADING PROTEIN DEGRADATION MINDS:
DALIA BARSYTE-LOVEJOY
Principal Investigator
Structural Genomics Consortium, University of Toronto
DAN NOMURA
Professor
UC Berkeley
DANETTE DANIELS
Vice President
Foghorn Therapeutics
DONG SEOK KIM
Chief Executive Officer
Aevis Bio
ERIC FISCHER
Principal Investigator
Dana Farber Cancer Institute
ERIK JONSSON
Senior Scientist
Bristol Myers Squibb
GWENN HANSEN
Chief Scientific Officer
Nurix Therapeutics
MASAHIKO HAYAKAWA
Vice President, Head of Targeted Protein Degradation
Astellas Pharma Inc.
View All TPD Speakers
2023 PARTNERS
LEAD PARTNER
PROGRAM PARTNERS
WORKSHOP HOSTING PARTNER
PROGRAM PARTNERS
INNOVATION PARTNERS
INDUSTRY PARTNERS
EXHIBITION PARTNERS
EVENT PARTNER
OTHER EVENTS IN THE SMALL MOLECULES & TPD WORLD SERIES
2023 EVENT GUIDE
REGISTER HERE
PARTNER WITH US
BACK TO THE TOP
VENUE
The Westin Copley Place
10 Huntington Ave,
Boston, MA 02116
United States
LOCATION
OUR CONTACT DETAILS
Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188
Email
info@hansonwade.com
JOIN OUR TEAM
We are always looking for ambitious people to join our team. You'll have
opportunities to learn quickly, advance your career, and to meaningfully impact
our customers and our business.
Click here to learn about careers.
ABOUT US
Hanson Wade specializes in scientific research across a comprehensive range of
distinctive R&D areas. We deliver insight and connections to facilitate safe and
effective drug development for more personalized and targeted patient
populations.
EXPLORE OUR PRODUCTS
Conferences Beacon Searchlight Intelligence
SEARCH
Search
ORGANIZED BY
Terms & Conditions
Privacy Policy
A Hanson Wade Group Company
© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade
Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.
We use cookies to ensure that we give you the best experience on our website. If
you continue to use this site we will assume that you are happy with it.Ok